Last reviewed · How we verify
Metformin Intensive exercise
At a glance
| Generic name | Metformin Intensive exercise |
|---|---|
| Also known as | GlumetzaTM 500 mg Extended Release |
| Sponsor | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Conventional vs Intensive Management on Gestational Diabetes and Maternal Fetal Outcomes (NA)
- Study of Acupuncture to Control Weight and Improve Pregnancy Rates in Overweight/Obese PCOS Patients (NA)
- METformin and FINGER Intervention to Prevent Cognitive Impairment and Disability in Older Adults at Risk for Dementia (PHASE2)
- Insulin Resistance and Mild Cognitive Impairment (IRMCI) Study (PHASE4)
- Research of Intensive Lifestyle Intervention for PCOS Patients With IGT (NA)
- Preventing Diabetes (NA)
- Diabetes Prevention Program (PHASE3)
- Effect of Medical Interventions in Insulin Resistance on Prevalence of Abnormal Glucose Tolerance (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: